E-LIB Suche - Ergebnisse für: Licitra, L.

1

Pembrolizumab with or Without Lenvatinib As First-line Ther..:

Licitra, L. ; Tahara, M. ; Harrington, K....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e2-e3 , 2024

Link: https://doi.org/10.1016/..

2

Final analysis of phase II results with cemiplimab in metas..:

Lewis, K.D. ; Peris, K. ; Sekulic, A....
Annals of Oncology. 35 (2024) 2 - p. 221-228 , 2024

Link: https://doi.org/10.1016/..

3

Health-Related Quality of Life (HRQoL) Data From KEYNOTE-41..:

Machiels, J.P. ; TAO, Y. ; Burtness, B....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e39-e40 , 2024

Link: https://doi.org/10.1016/..

4

Lenvatinib ± Pembrolizumab Versus Chemotherapy for Recurren..:

Harrington, K. ; Kim, H.R. ; Salas, S....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e42 , 2024

Link: https://doi.org/10.1016/..

5

Zanzalintinib Plus Pembrolizumab Versus Pembrolizumab Alone..:

Saba, N.F. ; Harrington, K. ; Licitra, L....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e40-e41 , 2024

Link: https://doi.org/10.1016/..

6

MO-0717 Seasonality of radiotherapy efficacy for head & nec..:

Blanchard, P. ; Lacas, B. ; Bourhis, J....
Radiotherapy and Oncology. 182 (2023) - p. S587-S588 , 2023

Link: https://doi.org/10.1016/..

7

Pembrolizumab versus methotrexate, docetaxel, or cetuximab ..:

Harrington, K.J. ; Cohen, E.E.W. ; Soulières, D....
Oral Oncology. 147 (2023) - p. 106587 , 2023

Link: https://doi.org/10.1016/..

8

Phase 2 LEAP-009: Lenvatinib (Lenva) With or Without Pembro..:

Harrington, K. ; Cohen, E. ; Siu, L....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e43-e44 , 2022

Link: https://doi.org/10.1016/..

9

Genomic Adjusted Radiation Dose (GARD) Predicts Overall Sur..:

Ho, E. ; De Cecco, L. ; Cavalieri, S....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S143 , 2022

Link: https://doi.org/10.1016/..

10

Trilynx: A Phase 3 Trial of Xevinapant and Concurrent Chemo..:

Schoenfeld, J.D. ; Cohen, E. ; Nutting, C.M....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e20-e21 , 2022

Link: https://doi.org/10.1016/..

11

A Clinically Translatable, Extensively Validated Immune-bas..:

Zeng, P. ; Cecchini, M. ; Barrett, J....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e5-e6 , 2022

Link: https://doi.org/10.1016/..

12

Organic phantom study of MRI-radiomic features repeatabilit..:

Tenconi, C. ; Bologna, M. ; Corino, V....
Physica Medica. 92 (2021) - p. S47-S48 , 2021

Link: https://doi.org/10.1016/..

13

Late toxicities burden in patients with radioiodine-refract..:

Platini, F. ; Cavalieri, S. ; Alfieri, S....
Endocrine. 73 (2021) 3 - p. 641-647 , 2021

Link: https://doi.org/10.1007/..

14

Reprint of "Squamous cell carcinoma of the oral cavity, lar..:

Machiels, J.-P. ; René Leemans, C. ; Golusinski, W....
Oral Oncology. 113 (2021) - p. 105042 , 2021

Link: https://doi.org/10.1016/..

15

OC-0642 A radiomics based prognostic model for patients wit..:

Keek, S. ; Wesseling, F. ; Woodruff, H....
Radiotherapy and Oncology. 161 (2021) - p. S509-S510 , 2021

Link: https://doi.org/10.1016/..